Exhibition Information
展会简介
The Exhibition Value of CPHI & PMEC China
- A Core Gateway for the Pharmaceutical Industry in the Guangdong–Hong Kong–Macao Greater Bay Area: As the southern extension of CPHI China, the world’s premier pharmaceutical exhibition, this event is strategically positioned as a hub for the biopharmaceutical industry in the Greater Bay Area. The region’s health‑care GDP is projected to surpass RMB 2 trillion by 2028 and reach RMB 2.5–3 trillion by 2030, providing enterprises with a strategic springboard to expand into the South China market and tap into the Greater Bay Area’s innovative resources.
- Comprehensive Coverage of the Entire Industry Ecosystem: The exhibition features a full spectrum of offerings, spanning APIs and intermediates, biopharmaceuticals, pharmaceutical excipients, contract development and manufacturing organizations (CDMOs), natural extracts, finished dosage forms, pharmaceutical machinery, packaging equipment, cleanroom technologies, laboratory instruments, and more—covering every segment of the value chain. By 2025, the show will double in size to 30,000 square meters, bringing together over 600 leading companies, while introducing a dedicated medical‑aesthetic supply‑chain zone to meet the rapidly growing consumer‑healthcare sector.
- An International Resource‑Linking Hub: Leveraging the global network cultivated by its parent event, CPHI China, and Informa Markets’ international footprint, the exhibition attracts tens of thousands of professional visitors from more than 40 countries and regions. In alignment with the Greater Bay Area’s policy of opening up to the world, and capitalizing on the advantages of the RCEP framework and the China–Europe Railway Express, the event provides an efficient trade platform for companies seeking to expand into Belt and Road markets and emerging Asian economies.
- Over 20 High‑Profile Forums Empowering Industry Leaders: Concurrently held are more than 20 high‑level conferences, including the Pharmaceutical Quality Development Summit, the Seminar on High‑Quality Global Expansion for Pharmaceutical Enterprises, the Peptide Industry Innovation and Ecosystem Development Conference, and the Greater Bay Area Pharmaceutical Manufacturing 4.0 Forum. These events bring together regulatory authorities, academic experts, and corporate executives to engage in in‑depth discussions on critical topics such as new drug discovery, process optimization, CXO collaborations, overseas expansion strategies, synthetic biology, and smart manufacturing, offering authoritative guidance for strategic decision‑making.
- Effective Precision Business Matching: Through targeted buyer‑seller matchmaking sessions and factory tours, the exhibition establishes one‑on‑one, precision‑driven connections between exhibitors and international procurement decision‑makers, fostering deep links between supply and demand and facilitating concrete collaborative opportunities.
- An Innovative “Exhibition + Conference” Model for Comprehensive Empowerment: Under the theme “Quality Upgrading through Innovation and Diversified Integration,” the event creatively integrates exhibitions with high‑end conferences, creating a multifunctional platform that combines technical exchanges, industrial partnerships, and trend insights. During the show, specialized zones for laboratory instruments and themed forums are also hosted, bringing together leading companies from niche segments such as Shandong Donglai, Shanghai Yuanhuai, and Germany’s Neopattec, showcasing the powerful momentum of innovative technologies driving scientific research.





